Gandhinagar, India

Vijay Chauthaiwale

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 9.6

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • Gujarat, IN (2012 - 2013)
  • Gujrat, IN (2014)
  • Gandhinagar, IN (2013 - 2019)

Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Vijay Chauthaiwale

Introduction

Vijay Chauthaiwale is a prominent inventor based in Gandhinagar, India. He has made significant contributions to the field of pharmaceuticals, holding a total of nine patents. His work focuses on developing innovative solutions for medical treatments, particularly in the area of inflammatory bowel disease.

Latest Patents

One of his latest patents is a low dose pharmaceutical composition that includes a therapeutically effective amount of a specific compound. This invention aims to treat inflammatory bowel disease in mammals by administering a low dose of the composition. Another notable patent involves novel fused imidazobenzothiazole compounds, which include various derivatives and their pharmaceutically acceptable compositions. These compounds are intended for use in the preparation of medicaments for pharmaceutical applications.

Career Highlights

Vijay Chauthaiwale is currently associated with Torrent Pharmaceuticals Limited, a leading company in the pharmaceutical industry. His work at Torrent has allowed him to focus on innovative drug development and contribute to advancements in medical treatments.

Collaborations

Some of his notable coworkers include Chaitanya Dutt and Sanjay Srivastava. Their collaboration has fostered a productive environment for research and development within the company.

Conclusion

Vijay Chauthaiwale's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through effective treatments. His patents reflect a deep understanding of medicinal chemistry and a dedication to addressing critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…